Timothy P Clackson - Net Worth and Insider Trading
Timothy P Clackson Net Worth
The estimated net worth of Timothy P Clackson is at least $6 Million dollars as of 2024-04-27. Timothy P Clackson is the President, R&D, CSO of ARIAD Pharmaceuticals Inc and owns about 197,884 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $5 Million. Timothy P Clackson is also the President and CEO of Theseus Pharmaceuticals Inc and owns about 351,030 shares of Theseus Pharmaceuticals Inc (THRX) stock worth over $1 Million. Details can be seen in Timothy P Clackson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Timothy P Clackson has not made any transactions after 2022-11-11 and currently still holds the listed stock(s).
Transaction Summary of Timothy P Clackson
Timothy P Clackson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy P Clackson owns 7 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , Forma Therapeutics Holdings Inc (FMTX) , and ARIAD Pharmaceuticals Inc (ARIA) among others .
Click here to see the complete history of Timothy P Clackson’s form 4 insider trades.
Insider Ownership Summary of Timothy P Clackson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-09-30 | director |
| FMTX | Forma Therapeutics Holdings Inc | 2020-06-18 | director |
| ARIA | ARIAD Pharmaceuticals Inc | 2017-02-16 | President & R&D & CSO |
| FSTX | F-star Therapeutics Inc | 2018-03-01 | director |
| THRX | Theseus Pharmaceuticals Inc | 2022-11-11 | director & President and CEO |
| ELEV | Elevation Oncology Inc | 2021-06-24 | director |
| XLO | Xilio Therapeutics Inc | 2021-10-21 | 10 percent owner |
Timothy P Clackson Latest Holdings Summary
Timothy P Clackson currently owns a total of 2 stocks. Among these stocks, Timothy P Clackson owns 197,884 shares of ARIAD Pharmaceuticals Inc (ARIA) as of October 24, 2016, with a value of $5 Million and a weighting of 76.91%. Timothy P Clackson also owns 351,030 shares of Theseus Pharmaceuticals Inc (THRX) as of November 11, 2022, with a value of $1 Million and a weighting of 23.09%.
Latest Holdings of Timothy P Clackson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2016-10-24 | 197,884 | 23.99 | 4,747,237 |
| THRX | Theseus Pharmaceuticals Inc | 2022-11-11 | 351,030 | 4.06 | 1,425,182 |
Holding Weightings of Timothy P Clackson
Timothy P Clackson Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy P Clackson has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 19,638 shares on October 24, 2016, which brought Timothy P Clackson around $187,739.
According to the SEC Form 4 filings, Timothy P Clackson has made a total of 2 transactions in Theseus Pharmaceuticals Inc (THRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Theseus Pharmaceuticals Inc is the acquisition of 2,500 shares on November 11, 2022, which cost Timothy P Clackson around $17,000.
Insider Trading History of Timothy P Clackson
- 1
Timothy P Clackson Trading Performance
GuruFocus tracks the stock performance after each of Timothy P Clackson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy P Clackson is 71.58%. GuruFocus also compares Timothy P Clackson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy P Clackson within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy P Clackson's insider trading performs compared to the benchmark.
Performance of Timothy P Clackson
Average Return
32.54%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.01 | 71.58 | 50.45 | 32.54 | 52.26 | -1.37 |
| Relative Return to S&P 500(%) | 2.19 | 68.99 | 51.1 | 32.95 | 47.19 | -15.44 |
Timothy P Clackson Ownership Network
Ownership Network List of Timothy P Clackson
Ownership Network Relation of Timothy P Clackson
Timothy P Clackson Owned Company Details
What does Spring Bank Pharmaceuticals Inc do?
Who are the key executives at Spring Bank Pharmaceuticals Inc?
Timothy P Clackson is the director of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , director & President and CEO Martin J Driscoll , and Chief Scientific Officer Radhakrishnan P. Iyer .
Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spring Bank Pharmaceuticals Inc Insider Transactions
Timothy P Clackson Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy P Clackson. You might contact Timothy P Clackson via mailing address: C/o Ariad Pharmaceuticals Inc, 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
